FDA product code QTE: Thymidine Kinase Activity

QTE is the FDA product code for thymidine kinase activity. It is a Class II device, regulated under 21 CFR 866.6010 and reviewed by the Immunology panel. FDA has cleared 1 510(k) submission under QTE, 1 in the last five years. The average 510(k) review took 669 days (median 669).

Definition

In vitro test to measure thymidine kinase activity (TKa) to aid in monitoring disease progression of breast cancer patients.

Classification

FieldValue
Device nameThymidine Kinase Activity
Device classClass II
Regulation21 CFR 866.6010
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)

510(k) clearances per year for QTE

YearClearancesAvg. review days
20221669

Compare with all 510(k) review times · Search every QTE clearance

Top QTE applicants

ApplicantClearancesLatest
Biovica International AB12022-07-29

Most recent QTE clearances

510(k)ApplicantDeviceDecision dateReview days
K202852Biovica International ABDiviTum TKa2022-07-29669

Recalls for QTE devices

openFDA lists no recalls for product code QTE.

Frequently asked questions

What is FDA product code QTE?

QTE is the FDA product code for thymidine kinase activity. It is a Class II device, regulated under 21 CFR 866.6010 and reviewed by the Immunology panel.

What device class is QTE?

Class II, regulation 21 CFR 866.6010. Typical premarket route: 510(k).

How long does a 510(k) take for product code QTE?

Across 1 cleared submissions the average was 669 days from receipt to decision (median 669).

Which companies have the most QTE clearances?

Biovica International AB (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times